Svetlana Shalnova

Prof. Svetlana Shalnova


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 December 2014 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
GMG. A. Muromtseva
G. A. Muromtseva
AKA. V. Kontsevaya
A. V. Kontsevaya
VKV. V. Konstantinov
V. V. Konstantinov
GAG. V. Artamonova
G. V. Artamonova
TGT. M. Gatagonova
T. M. Gatagonova
GTG. V. Tolparov
G. V. Tolparov
In the frame of Multicenter observational study ECVD-RF (Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation) by the unique protocol the investigation of representative selections of adult population at the age of 25-64 y.o. of 11 regions RF (n=18305, including males, n=6919 and females n=11386): Volgograd, Vologda, Voronezh, Ivanovo, Kemerovo, Orenburg, Samara, Tomsk, Tyumen, Saint-Petersburg and Northern Osetia-Alania. The prevalence of the following risk factors (RF) of cardiovascular diseases is evaluated: high blood pressure — 33,8%, obesity — 29,7%, high total cholesterol — 57,6%, high glucose level or diabetes — 4,6%, smoking (tobacco consumption) — 25,7%, insufficient (low) level of physical activity — 38,8%, excessive salt consumption — 49,9% and insufficient vegetables and fruits consumption — 41,9%. Gender differences and an increase with the age of the parameters mentioned are described.The absence of a epidemiologic monitoring system at the Federal level leads to an impossibility of clear conclusions on the RF dynamics in Russian population. While comparing the ECVD-RF study with previous epidemiological studies we can just cautiously suppose the existence in 21st age of negative dynamics of one RF (obesity, dyslipidemia) and positive dynamics of the others (smoking).

1 March 2019 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ROR. G. Oganov
R. G. Oganov
VSV. I. Simanenkov
V. I. Simanenkov
IBIgor G. Bakulin
Igor G. Bakulin
NBN. V. Bakulina
N. V. Bakulina
OBOlga Barbarash
Olga Barbarash
ЮКЮ. В. Котовская
Ю. В. Котовская
Коморбидная патология в клинической практике. Алгоритмы диагностики и лечения

1 October 2014 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
GSGabriel Steg
Gabriel Steg
NGNicola Greenlaw
Nicola Greenlaw
MTMichal Tendera
Michal Tendera
JTJean-Claude Tardif
Jean-Claude Tardif
RFRoberto Ferrari
Roberto Ferrari
KFKim M. Fox
Kim M. Fox
Major changes have occurred in the management of coronary artery disease (CAD), with increasing use of revascularization1 and effective evidence-based secondary prevention therapies, such as lifestyle interventions, statins, angiotensin-converting enzyme inhibitors, and antiplatelet agents, and the availability of newer antianginals. These factors have dramatically changed the presentation, management, and prognosis among patients with stable CAD.2

31 August 2021 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
SBSergey Boytsov
Sergey Boytsov
ODOxana M. Drapkina
Oxana M. Drapkina
ESE. V. Shlyakhto
E. V. Shlyakhto
AKA. O. Konradi
A. O. Konradi
YBYulia Balanova
Yulia Balanova
SSSvetlana Shalnova
Svetlana Shalnova
The growing weight of noncommunicable diseases, primarily cardiovascular diseases (CVDs), is a great threat to the health of population worldwide, worsening the quality of life and reducing life expectancy. Realization of this threat led to initiation of epidemiological study by the Russian Ministry of Health to investigate the prevalence of CVDs and their risk factors, since it is CVDs that specify the high allcause mortality in Russia. In the modern history of epidemiology of non-infectious disease, the Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation (ESSE-RF) study occupies a special place. This is the largest epidemiological study, which is considered as a continuation of preventive activity in order to obtain unbiased information on epidemiological characteristics of population in Russian regions. To conduct the study, the Research Organizing Committee of ESSE-RF study was created and a protocol was developed. All interested scientists and experts from following three centers took part in the work: National Medical Research Center for Therapy and Preventive Medicine, Almazov National Medical Research Center, National Medical Research Center of Cardiology. The Russian regions were justified and selected for participation. In 2012-2014 ESSE-RF study, 13 following Russian regions took part: Volgograd, Vologda, Voronezh, Ivanovo, Kemerovo, Tyumen Oblasts; Krasnoyarsk and Primorsky Krai; the Republic of North Ossetia (Alania); cities of Orenburg, Samara, St. Petersburg and Tomsk. All participated regions used a single study protocol, while biochemical parameters were determined in Federal centers using the same equipment and reagent kits. The paper presents some of the most interesting results that indicate a change in Russian epidemiological situation over the past few years. After the end of cross-sectional study, a field of priority research areas was formed in each center.Conclusion. Epidemiological studies are the most important scientific tool for assessing the prevalence of diseases, their risk factors, as well as predicting adverse events. Based on the results obtained, healthcare system and medical community determine priorities and develop related strategies (population-based and high-risk strategies). For their implementation, a regulatory and legal framework is being created.

28 December 2023 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
YBYulia Balanova
Yulia Balanova
ODOxana M. Drapkina
Oxana M. Drapkina
VKVladimir Kutsenko
Vladimir Kutsenko
AIAsiia (Asiya) Imaeva
Asiia (Asiya) Imaeva
AKA. V. Kontsevaya
A. V. Kontsevaya
ЮШЮ. Ю. Шамурова
Ю. Ю. Шамурова
Aim. To study the epidemiological characteristics and changes of hypertension (HTN), as well as factors associated with HTN in the Russian population aged 35-74 years.Material and methods. The Epidemiology of Cardiovascular Diseases and their Risk Factors in Regions of Russian Federation-3 (ESSE-RF3) study examined a representative sample of the population aged 35-74 years of 15 Russian regions with a response >70% (n=28611). Modular design questionnaire was used. Blood pressure (BP) was measured twice after a 5-minute rest in a sitting position on the right arm with an Omron blood pressure monitor. There were following criteria for hypertension: systolic blood pressure (SBP) ≥140 mm Hg and/or diastolic blood pressure (DBP) ≥90 mm Hg, and/or antihypertensive therapy. The effectiveness of treatment was considered the proportion (%) of people who achieved target blood pressure values among those being treated, while the control was considered the proportion (%) of patients with a BP <140/90 mm Hg of the total number of hypertensive patients. HTN changes were studied in a single age range of 35-64 years with the inclusion of materials from the ESSE-RF (2012-14) and ESSE-RF2 (2017) studies, carried out using the same methodology as ESSE-RF3. Statistical analysis was carried out using the open-source R 3.6.1 environment. Analysis of the association between factors and a binary variable was performed using logistic regression. The significance level for all tested hypotheses was 0,05.Results. According to ESSE-RF3, the average levels of SBP and DBP in the population were 131,9±18,7 and 84,4±10,9 mm Hg, respectively, while the proportion of those with BP ≥140/90 mm Hg — 38,8% (men: 44,8%, women: 33,9%). Prevalence of hypertension was 53,9% (men: 56,0%, women: 52,1%), awareness — 77,7% (men: 71,5%, women: 82,3%), while the treatment received 63,4%, significantly higher among women than among men: 72,3 vs 53,3%. The effectiveness of treatment was 44,0%, higher among women compared to men (48,2 vs 37,4%). In addition, 27,9% of patients have controlled HTN.Conclusion. The problem of controlled HTN in Russia remains unresolved in the 21st century. The following significant sex differences remain: the prevalence of HTN is higher among men, but awareness of the disease, treatment rate and its effectiveness are lower compared to women.

5 June 2022 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ODOxana M. Drapkina
Oxana M. Drapkina
SSSvetlana Shalnova
Svetlana Shalnova
AIAsiia (Asiya) Imaeva
Asiia (Asiya) Imaeva
YBYulia Balanova
Yulia Balanova
Sergey MaksimovSergey Maksimov
Sergey Maksimov
AKA. V. Kontsevaya
A. V. Kontsevaya
Previous studies have shown significant differences in the health status of the population depending on the place of residence. Despite the ongoing preventive measures, there is no improvement in the epidemiological situation in relation to noncommunicable diseases, including due to unfavorable living conditions. This study is a continuation of the following earlier studies: Epidemiology of Cardiovascular Diseases in Regions of Russian Federation (ESSE-RF) and ESSE-RF-2.Aim. To assess the prevalence of cardiovascular diseases, various risk factors (RFs) of these diseases and their association in Russian regions with different economic, climate and geographic characteristics to determine the risk profile of the region and develop approaches to targeted prevention programs specific to the regions.Material and methods. The study selected 30 regions representing each federal district of the Russian Federation. The survey of participants is carried out in three stages as follows: survey using an original modular questionnaire; measurements, including anthropometry, hand grip strength test, blood pressure and heart rate assessment; blood sampling, followed by biobanking and laboratory tests.Conclusion. The results obtained will allow deepening knowledge about the RF profile specific to a particular region, evaluating the effectiveness of preventive programs, and planning new ones taking into account regional and socio-demographic characteristics. This will become the basis for a better understanding of the socio-economic burden of noncommunicable diseases and the economic damage of RFs.